BRN BARNWELL INDUSTRIES INC Insider Trading

Director Horowitz purchases 4,433 shares at $1.05 (4th buy in 15 months; prior BRN buys underperformed at 90d).

Joshua Horowitz acquired 4,433 shares at $1.05, expanding his stake by 1.4% to 319,709 shares total. This is his fourth purchase of BRN stock within 15 months, following earlier buys on 2025-11-24 and 2024-08-21/23. However, his same-ticker history at BRN shows a consistent pattern of underperformance: all four prior buys registered negative or flat 90-day returns, with cumulative 90-day outcomes of -8.2%, -8.2%, -26.6%, and -24.6%. The current stock price of $1.14 is down 10.2% over 90 days and trades 42.4% below its 52-week high. The company faces operational headwinds: revenue declined 37.0% year-over-year, the latest quarter posted a $-1.4M net loss, and market cap stands at $14.3M with negative full-year earnings. Repeated accumulation at a small-cap trading well below prior highs, combined with a persistent pattern of 90-day underperformance on this ticker and deteriorating fundamentals, suggests a speculative holding rather than a vote of operational confidence.

Director Horowitz buys 59,563 shares at $1.10 in 2 transactions; holdings up 23.3% to 315.3K shares amid -41.9% drawdown from 52-week high

Joshua Horowitz, Director at Barnwell Industries, made 2 separate open-market purchases totaling 59,563 shares for $65,519.30 at $1.10 per share on 2025-11-24, expanding his holdings by 23.3% to 315.3K shares. The current stock price of $1.15 is -41.9% from its 52-week high and -5.0% over the past 30 days, placing the purchases near recent lows. However, Horowitz's prior trades at BRN show mixed timing: his 2 previous buys (August 2024) generated -0.0% and +2.6% 30-day returns but declined -26.6% and -24.6% over 90 days, with 0 of 2 prior buys well-timed at the 90-day mark. The company reported a net loss of $1,550,000.00 in the latest quarter and -14.0% annual revenue decline, with unprofitable full-year results. A cluster pattern is present with 2 other insiders also buying within the past 14 days, suggesting coordinated activity rather than isolated conviction.

Director Grossman buys 59,563 shares of BRN at $1.10; cluster of 3 insider buys in 14 days amid -14.0% revenue decline

Director Kenneth S Grossman purchased 59,563 shares at $1.10 on 2025-11-24, increasing his holdings by 28.1% from 212,040 to 271,603 shares. This transaction is part of a cluster pattern with 2 other insiders buying within the past 14 days, suggesting coordinated or coincident conviction at current price levels. However, the underlying fundamentals present a contrasting picture: the company reported Revenue $3,192,000.00 and Net income $-1,550,000.00 in its latest quarter, with Annual revenue growth (FY vs prior FY) of -14.0%, and the company was unprofitable over its most recent full fiscal year. The stock has declined 41.9% from its 52-week high of $1.98 and is currently trading at $1.15, only 4.5% above the transaction price. The convergence of meaningful insider accumulation with material operational headwinds and negative financial trajectory warrants close examination of management's forward guidance and the drivers behind this buying activity.

EVP Finance Patman buys 43.8K shares of BRN at $1.10; 2 other insiders bought within 14 days amid -14.0% annual revenue decline and unprofitability

Patman Philip F Jr, Executive VP - Finance, purchased 43,796 shares at $1.10, increasing his holdings by 26.3% to 210,211 shares. This transaction is notable in context: the company reported Net income $-1,550,000.00 for the latest quarter, annual revenue growth of -14.0% year-over-year, and a market cap of $11,584,564.10. The stock currently trades at $1.15, down 5.0% over 30 days and -41.9% from its 52-week high of $1.98. A cluster pattern is visible—2 other insiders also purchased within the past 14 days—suggesting coordinated accumulation at depressed levels. The convergence of insider buying during a period of material operational headwinds (negative net income, revenue contraction) and significant stock underperformance warrants scrutiny of the company's near-term outlook and whether insiders possess material non-public information regarding a potential turnaround or stabilization.

CEO Hopkins Craig Douglas bought 10,000 shares of BRN at $1.65; prior BRN buys both underperformed 90-day mark, company unprofitable.

Hopkins Craig Douglas, Chief Executive Officer, purchased 10,000 shares at $1.65 on 2025-01-17, increasing his holdings from 141,000 to 151,000 shares. His two prior purchases at BRN (on 2024-08-29 and 2024-08-28) both declined over the 90-day period, with losses of -29.2% and -27.0% respectively; neither trade was well-timed at the 90-day mark. The company's latest quarterly revenue was $5.5M with net income of $-1.2M, and annual revenue contracted -14.0% year-over-year while the firm remains unprofitable. The current price of $1.65 sits 44.1% below the 52-week high of $2.95, though up 15.4% over the past 30 days.

BRN President/CEO buys 10,000 shares across 2 transactions for $24,349.50; company unprofitable, -11.5% annual revenue growth

Hopkins Craig Douglas, President and CEO, purchased 10,000 shares in 2 separate transactions on 2024-08-28 and 2024-08-29 at blended average price of $2.43, increasing his holdings from 65,000 shares to 75,000 shares (+15.4%). The purchase occurs within the 52-week range ($2.17–$2.95) and near current price of $2.44. However, material financial headwinds characterize the company: net income was $-1,246,000.00 (negative), latest quarterly revenue is $5,527,000.00 with annual revenue declining -11.5% year-over-year, and the company was unprofitable over its most recent full fiscal year. The insider's acquisition of a 15.4% increase in holdings during a period of financial deterioration warrants scrutiny regarding motivation—particularly whether this represents conviction in a recovery scenario or reflects alternative strategic considerations not evident in public fundamentals.

Director Joshua Horowitz buys 17,096 shares at $2.28 avg (2 txns): $38,927.31 in BRN stock near 52-week lows

Joshua Horowitz, a director at Barnwell Industries, made 2 separate open-market purchases totaling 17,096 shares (17.1K shares) for $38,927.31 ($38.9K) at a blended average price of $2.28, increasing his holdings by 6.8% to 270,276 shares (270.3K shares). The purchases occurred near the lower end of the 52-week range ($2.17–$2.95), with the current price at $2.32 down 21.4% from the 52-week high and down 15.9% over 90 days. Historically, Horowitz's prior purchases at Barnwell Industries show strong timing: 4 of 5 prior buys delivered positive 90-day returns, with cumulative 90d gains of +23.8%, +26.0%, +30.9%, +7.0% across those trades. However, the company context is challenging—latest quarterly revenue was $5,527,000.00 ($5.5M) with a net loss of $1,246,000.00 ($-1.2M), and annual revenue declined 11.5% year-over-year. The purchase volume and price level suggest consistent accumulation in a structurally challenged micro-cap, though the insider's prior success at timing these positions at Barnwell warrants observation of whether that pattern persists.